Combined Therapy with a CCR2/CCR5 Antagonist and FGF21 Analogue Synergizes in Ameliorating Steatohepatitis and Fibrosis.
Puengel T, Lefere S, Hundertmark J, Kohlhepp M, Penners C, Van de Velde F, Lapauw B, Hoorens A, Devisscher L, Geerts A, Boehm S, Zhao Q, Krupinski J, Charles ED, Zinker B, Tacke F.
Puengel T, et al. Among authors: van de velde f.
Int J Mol Sci. 2022 Jun 15;23(12):6696. doi: 10.3390/ijms23126696.
Int J Mol Sci. 2022.
PMID: 35743140
Free PMC article.